Hello, everyone, and how are you today? We hope the weekend was refreshing and invigorating. Interestingly, the forecast calls for an unseasonably warm day here on the Pharmalot corporate campus and throughout the surrounding region. To cope, we are brewing a delicious cup of stimulation. A hot day calls for a hot drink. We invite you to join us as we all gear up for another round of meetings and deadlines. Meanwhile, here are some tidbits. Hope your day goes well and stay in touch...
Merck Strikes Cancer Drug Deal With Endocyte (Bloomberg News)
Merck Tries Promoting Shingles Vaccine Again (Dow Jones)
Industry Comments To FDA On Biosimilars Reflect Discontent (GenEnNews)
ViroPharma Sues FDA Over Rejected Petition (FDA Law Blog)
Merck To FDA: Better Definition Of Crude Heparin Is Needed (InPharma Technologist)
Express Scripts Tries New Product To Improve Patient Compliance (Associated Press)
French Drugmakers Are Reeling (Financial Times)
South Africa Increases Protection For Domestic Drugmakers (Business Day)
Cetero Sale Timetable Is Extended (Outsourcing Pharma)
EDITOR'S NOTE: Please check this post for updates throughout the day
sunrise pic thx to benimoto on flickr